Core Viewpoint - Central Garden & Pet Company reported mixed results for Q1 fiscal 2026, with revenues missing estimates but earnings exceeding expectations, reflecting improved margins despite challenges in sales performance [2][3]. Financial Performance - Adjusted earnings were 21 cents per share, surpassing the Zacks Consensus Estimate of 11 cents, remaining flat year over year [3]. - Net sales were $617.4 million, down 6% year over year, and below the Zacks Consensus Estimate of $644 million, primarily due to shipment timing and portfolio optimization [4]. - Gross profit totaled $190.6 million, a 3% decline year over year, but gross margin improved by 110 basis points to 30.9% [5]. - Operating income decreased to $16.5 million from $28 million in the prior year, with adjusted operating income at $24.3 million, down 13% year over year [6]. Segment Performance - The Pet segment generated $416 million in sales, down 3% year over year, affected by portfolio optimization and shipment timing [7]. - The Garden segment reported net sales of $202 million, down 12% year over year, largely due to shipment timing and category rationalization [9]. Financial Health - The company ended the quarter with cash and cash equivalents of $721.2 million and long-term debt of $1,192.1 million, resulting in a gross leverage ratio of 2.9 [12]. - During the quarter, Central Garden repurchased 660,000 shares for $18.5 million, with $28 million remaining under its current authorization [13]. Outlook - Management reaffirmed its expectation for fiscal 2026 non-GAAP earnings of $2.70 per share or better, supported by margin discipline and cost efficiency initiatives [14]. - Estimates for the stock have been trending upward, with a Zacks Rank of 2 (Buy), indicating expectations for above-average returns in the coming months [17].
Central Garden (CENT) Up 2.4% Since Last Earnings Report: Can It Continue?